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Abstract
Background: Regulatory T cells (Treg) play a significant role in immune homeostasis and self-tolerance. Excessive sensitivity
of isolated Treg to apoptosis has been demonstrated in NOD mice and humans suffering of type 1 diabetes, suggesting a
possible role in the immune dysfunction that underlies autoimmune insulitis. In this study the sensitivity to apoptosis was
measured in T cells from new onset diabetic NOD females, comparing purified subsets to mixed cultures.
Principal Findings: Apoptotic cells are short lived in vivo and death occurs primarily during isolation, manipulation and
culture. Excessive susceptibility of CD25
+ T cells to spontaneous apoptosis is characteristic of isolated subsets, however
disappears when death is measured in mixed splenocyte cultures. In variance, CD25
2 T cells display balanced sensitivity to
apoptosis under both conditions. The isolation procedure removes soluble factors, IL-2 playing a significant role in
sustaining Treg viability. In addition, pro- and anti-apoptotic signals are transduced by cell-to-cell interactions: CD3 and
CD28 protect CD25
+ T cells from apoptosis, and in parallel sensitize naı ¨ve effector cells to apoptosis. Treg viability is
modulated both by other T cells and other subsets within mixed splenocyte cultures. Variations in sensitivity to apoptosis
are often hindered by fast proliferation of viable cells, therefore cycling rates are mandatory to adequate interpretation of
cell death assays.
Conclusions: The sensitivity of purified Treg to apoptosis is dominated by cytokine deprivation and absence of cell-to-cell
interactions, and deviate significantly from measurements in mixed populations. Balanced sensitivity of naı ¨ve/effector and
regulatory T cells to apoptosis in NOD mice argues against the concept that differential susceptibility affects disease
evolution and progression.
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Introduction
Autoimmune insulitis in NOD mice reflects a condition of
disturbed immune homeostasis that involves deregulation of both
effector (Teff) and regulatory T cells (Treg). Among multiple
aberrant mechanisms detected in NOD mice, emphasis on the
sensitivity to apoptosis has been intensely investigated as a possible
cause of persistent activity of diabetogenic clones and insufficiency
of suppressor mechanisms. Suppressor cells encompass a variety of
phenotypes and functions that include both naturally occurring
and adaptive regulatory T cells (Treg) [1–4]. For pragmatic
purposes, high-level expression of CD25 (the a chain of the high
affinity IL-2 receptor) is used for purification of naturally occurring
Treg [5], which is accompanied by the transcription factor FoxP3
[6]. These subsets are functionally distinct in NOD mice, with
CD25
2 naı ¨ve/effector T cells (Teff) transferring the disease
efficiently into immunocompromized mice, and CD25
+ Treg
blocking adoptive disease transfer [7–9]. The same isolation
procedure is widely used to assess various functions of Treg in vitro,
revealing suppression of Teff proliferation and IL-2 production as
major mechanisms of Treg-mediated suppression [10–12]. Rela-
tive resistance of T cells in general [13,14] and of effector cells in
particular [15,16], have been attributed a role in disease evolution
in NOD mice. These findings question whether differential
sensitivities of T cell subsets to apoptosis are involved in dominant
effector activity [17].
Increased apoptosis of CD4
+CD25
+/high T cells isolated by
FACS sorting and immunomagnetic antibodies from diabetic
patients suggests possible involvement in the pathogenesis this
autoimmune disorder [18–21]. However, despite the apparent
increased susceptibility to apoptosis, Treg are found at equal or
higher numbers in new onset diabetics and display primarily
functional deficits [22–25]. As a systemic autoimmune disorder,
high levels of circulating Treg reflect a physiological effort to
counteract inflammatory reaction, whereas increased susceptibility
to apoptosis is an apparent detrimental mechanism. Likewise,
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insulitis [26,27], and are found at excessive numbers in mutant
mice deficient in Fas-ligand (gld) [28]. Although defective negative
regulation in gld mice might lead to elevated Treg fractions within
the generalized lymphoproliferative state, it is unclear why
apoptotic cells are collected from wild type mice. Unlike the
proliferative anergy displayed by Treg in vitro [29,30], this subset
appears to cycle at faster rates in vivo [28,31], a possible cause of
increased mortality [17]. Alternatively, it is possible that Treg are
particularly susceptible to manipulation during isolation, manip-
ulation and culture and their death is primarily related to the
processing procedure. Our prior studies have demonstrated
efficient clearance of dead cells from the bone marrow, as
determined by intravital microscopy and focused irradiation of
labeled cells at the fluorochrome wavelength [32]. We therefore
hypothesize that dead cells are scarcely found in tissues under
steady state conditions, and death might occur during manipula-
tion.
The sensitivity of purified Treg is modulated by the proliferation
rates, cytokines, TCR engagement and the state of activation, and
most important by feedback interactions with cytotoxic T cells
[17]. Isolation of T cell subsets according to CD25 expression
relies on functional assays, where CD25
2 are largely composed of
naı ¨ve/effector cells and CD25
+ correspond to an enriched fraction
of naturally occurring Treg expressing FoxP3. For example,
CD25
2 T cells induce insulitis in immunocompromized hosts,
whereas CD25
+ T cells suppress adoptive disease transfer [7–9]. In
this study we assessed the sensitivity of CD25
2 and CD25
+ T cells
derived from new onset diabetic mice to spontaneous apoptosis in
cultures of purified cells and mixed populations. We found that the
isolation procedure is a dominant factor that affects the
susceptibility of CD25
+ T cells. Apoptosis of both effector and
regulatory cells is modulated both by IL-2 and cell-to-cell
interactions that transduce TCR-associated and costimulatory
signals.
Results
T cells isolated from lymphoid organs exhibit variations
in spontaneous apoptosis
The procedure of immunomagnetic isolation, composed of
negative selection of CD4
+ T cell and positive selection for CD25
within this subset, results in marked variability in lymphocyte
viability. These populations are functionally distinct, with CD25
2
cells adoptively transferring diabetes into 80% of NOD.SCID
mice, whereas CD25
+ T cells lacking diabetogenic activity and
repressing disease transfer [9,26,27,29]. A series of 19 isolation
procedures showed initial contents of dead cells ranging from
7.666.9% (range 0.4%–20%) and 14.3610.3% (range 0.8%–
33%) for CD25
2 and CD25
+ subsets respectively. Limiting the use
of these samples to 10% dead cells in each individual subset, 13
experiments were used with mean contents of 3.762.8% and
6.864% non-viable CD25
2 and CD25
+ cells, respectively. These
values fall within the range previously reported for the frequency
of apoptotic cells following cyclophosphamide challenge in vivo
[13]. Notably, differential staining showed 7-AAD uptake in
8965% of the cells which were negative for Annexin-V, indicating
non-specific membrane permeabilization as a feature of non-
apoptotic death. Since CD25
+ T cells are more sensitive to death
during the preparation procedure (p,0.05 vs CD25
2), these data
present a caution to experiments based on detection of differential
sensitivity to apoptosis of purified cells.
To evaluate the precision of measurements of dead cells in fresh
samples, NOD mice were infused with 5610
7 PKH-labeled dead
autologous splenocytes. After 2 hours, 12.863.4% of the infused
cells were found in the spleens and mesenteric lymph nodes of the
NOD recipients. These cells were not detected after 24 hours,
demonstrating fast clearance of dead cells entrapped in the
lymphoid organs.
Isolated CD25
+ T cells are more sensitive to apoptosis
than mixed cultures
To determine possible variations in susceptibility of CD4
+ T cell
subsets to apoptosis, cells were incubated for 48 hours under
conditions of cytokine deprivation. CD4
+ T cells isolated from wild
type (C57BL/6), prediabetic (14 weeks) and diabetic NOD mice
display disproportional sensitivity to apoptosis: 21–33% and 48–
62% of CD25
2 and CD25
+ cells succumb to apoptosis respectively
(p,0.01, Figure 1A). Increased apoptosis of CD25
+ cells isolated
from new onset diabetic mice is consistent with the reported
sensitivities of CD25
+ T cells isolated from wild type and gld (FasL-
defective) mice [28] as well as in humans [18–21]. However,
measurements of apoptosis performed by gating of CD4
+ T cell
subsets within mixed splenocyte populations show a very different
situation (Figure 1A). Increased mortality of CD25
+ T cells is
primarily a result of the isolation procedure (p,0.005), a feature
that is much less accentuated in the CD25
2 subset. Dissociation
between CD25
low (45%) and CD25
high (55%) subsets (Figure 1B)
in new onset diabetic NOD females disclosed excessive apoptosis
of isolated CD25
high cells (p,0.001 vs CD25
low), suggesting
particular dependence on factors released by adjacent cells such as
IL-2. Distinct behavior within the CD4
+ subset was further
assessed in reference to FoxP3 expression (Figure 1C), showing
increased sensitivity to apoptosis of FoxP3
+ cells (p,0.001 vs
FoxP3
2) in particular within the isolated CD25
+ subset (p,0.001
vs gated). These data document increased susceptibility to
apoptosis in culture of CD4
+ T cells displaying a phenotype of
naturally occurring Treg derived from wild type and NOD mice.
Soluble factors and cell-to-cell interactions affect cell
viability
Protection of CD25
+ T cells from apoptosis by adjacent cells
might be mediated by cytokines and cell-to-cell interactions. To
determine the role of soluble factors, cells were incubated with
conditioned medium of CD25
2 T cells stimulated in plates
containing bound anti-CD3 and CD28 antibodies [33,34].
Conditioned medium had little influence on apoptotic death of
isolated CD25
2 cells and partially reversed the excessive death of
CD25
+ cells (p,0.001, Figure 2A). Therefore, putative Treg are
partially protected from apoptosis in culture by soluble factors
released from adjacent populations. To determine the major
subsets that affect the sensitivity to apoptosis, B lymphocytes and
myeloid cells (GR-1
+ and MAC-1
+) were depleted from the mixed
cultures (Figure 2B). Since the isolation procedure appears to be a
process that sensitizes to apoptosis, we preferred exclusion of cells
rather than combining isolated cell subsets. In variance from the
small effect of depletion on CD25
2 cells, exclusion of B
lymphocytes and myeloid cells from the cultures partially
protected CD25
+ T cells from apoptosis (p,0.001). Overall, T
cells and other constituents of the spleen support the viability of
CD25
+ Treg in culture through release of soluble factors, and
possibly through cell-to-cell interactions.
Despite the apparent sensitization to apoptosis during the
isolation procedure, the distinct effect on CD4
+CD25
2 cells on
viability of isolates Treg was performed in co-culture experiments.
Incubation of isolated CD4
+CD25
+ T cells with an equal number
of isolated CD4
+CD25
2 was sufficient to reverse susceptibility of
T Cell Apoptosis in Diabetic NOD Mice
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balanced sensitivity to apoptosis characteristic of mixed cultures
(Figure 1A).
IL-2 induces cycling and improves the viability of CD25
+
T cells
IL-2 sensitizes T cells to apoptosis [35], however in an apparent
paradoxal manner cytokine withdrawal also results in marked
increase in susceptibility of Treg cells to apoptosis [36]. The
primary cytokine candidate of interaction between Treg and
naı ¨ve/effector T cells is supplementation of IL-2, an essential
cytokine that is avidly consumed and supports expansion, survival
and activity of Treg cells [37]. Exogenous IL-2 supplementation to
isolated CD25
+ T cells has a remarkable anti-apoptotic effect on
CD25
+ T cells (p,0.001, Figure 2A) while sensitizing CD25
2 cells
to apoptosis (p,0.001). Decreased fractional death is partially
caused by IL-2-mediated stimulation of CD25
+ T cell proliferation
(p,0.05, Figure 3B), diluting the apoptotic cells within a fast
cycling viable population. Likewise, IL-2 protects CD25
+ T cells
from apoptosis in mixed cultures (p,0.01, Figure 3C), a
phenomenon also associated with faster cycling of this subset
(Figure 3D). Therefore, pharmacological concentrations of IL-2
improve the survival of CD25
+ T cells, both as isolated subsets and
within bulk splenocyte populations. Furthermore, the endogenous
supply of IL-2 in mixed cultures is insufficient to attain the
maximal protective effect over cell viability conferred by this
cytokine.
CD3/CD28 stimulation protects isolated CD25
+ T cells
from apoptosis
Another parameter attenuated by cell isolation is interaction
between various cell subsets, including TCR-associated stimula-
tion. Such interactions are stipulated by the observation that the
suppressor activity of CD25
+ T cells depends on cell-to-cell
interactions [38,39] and the sensitivity to apoptosis is reciprocally
modulated in coincubations of effector and suppressor cells
[33,34]. Isolated CD25
- cells display increased rates of spontane-
ous apoptosis upon CD3 stimulation with no apparent additional
Figure 1. Impact of cell isolation on sensitivity to apoptosis. A. Apoptosis of CD4
+CD25
2 and CD4
+CD25
+ subsets measured after 48 hours in
isolated cell suspensions (n=5) and by gating in mixed cultures (n=5). Cells were harvested from wild type C57BL/6, prediabetic NOD females aged
14 weeks and new onset diabetic NOD mice. Representative measurements of 7-AAD and Annexin-V incorporation are shown for isolated and mixed
populations (gated) from diabetic NOD females. B. Differential apoptosis in reference to low and high CD25 expression measured in isolated CD25
+
subsets (n=4) and by gating in mixed cultures (n=5). C. Spontaneous apoptosis in reference to FoxP3 expression in the isolated CD25
+ subset (n=3)
and in mixed cultures (n=3).
doi:10.1371/journal.pone.0015684.g001
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2 and CD25
+ T cells isolated from new onset diabetic
NOD females were incubated for 48 hours in conditioned medium from CD25
2 T cells stimulated with surface-bound anti CD3 and anti-CD28
antibodies (n=3). Data are compared to corresponding measurements of isolated cells and mixed cultures. B. Spontaneous apoptosis after 48 hours
T Cell Apoptosis in Diabetic NOD Mice
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stimulation of fast cycling (p,0.01, Figure 4B). Although
proliferation sensitizes naı ¨ve T lymphocytes to apoptosis, expan-
sion of viable cells dilutes the dead fractions. Both stimulatory
signals protect isolated CD25
+ T cells from spontaneous apoptosis
(p,0.001, Figure 4A), with significantly smaller effects on
proliferation (Figure 4B). Isolated CD25
+ T cells maintain
fractional expression of the IL-2 receptor and FoxP3 under
CD3/CD28 stimulation (Figure 4C). These data are consistent
with prior demonstration of protective effects of TCR-associated
stimulation over isolated Treg cells and are consistent with
successful ex vivo expansion of this subset by these stimulatory
pathways [40].
Further analysis of isolated CD25
2 T cells reveals that CD3/
CD28 stimulation defines two distinct subsets. A minor fraction of
cells remain negative for the IL-2 receptor (Figure 4C), proliferate
at slow rates (Figure 4D) and are sensitive to apoptosis (p,0.001,
Figure 4E). The major fraction is induced to express CD25 and
CD69 without priming FoxP3 expression (Figure 4C), proliferate
at faster rates (p,0.01, Figure 4D) and display stable sensitivity to
apoptosis (Figure 4E). Although responsive cells (CD25
2RCD25
+)
display relatively stable levels of fractional apoptosis, fast turnover
of viable cells (Figure 4D) dilutes the true numbers of activated
apoptotic cells. Taken together, CD3 and CD28 stimulation
present dissociated effects on isolated CD4
+ subsets: increase the
sensitivity of isolated CD25
2 T cells to apoptosis irrespective of the
Figure 3. Influence of IL-2 on CD4
+ T cell apoptosis. A. Apoptosis of CD4
+CD25
2 (n=5) and CD4
+CD25
+ T cells (n=4) isolated from new onset
diabetic NOD females and incubated for 48 hours with and without 2000 U/ml IL-2. B. Demonstrative measurements of proliferation rates of isolated
CD25
2 and CD25
+ cells as determined from CFSE dilution (representative of 4 independent measurements). C. Impact of exogenous IL-2
supplementation on apoptosis measured by gating on CD25
2 and CD25
+ subsets in mixed cultures (n=4). D. Demonstrative plots of CFSE dilution in
gated CD4
+ subsets within mixed cultures (representative of 4 measurements).
doi:10.1371/journal.pone.0015684.g003
of culture of isolated CD25
+ T cells (n=4) and gated subsets in mixed cultures (n=5) following B220, GR-1 and MAC-1 depletion (n=4). C. Equal
numbers of isolated CD25
2 and CD25
+ T cells from diabetic NOD mice were mixed for determination of apoptosis after 48 hours of culture in the
CD25+ subset (gate). Data are representative of four independent incubations.
doi:10.1371/journal.pone.0015684.g002
T Cell Apoptosis in Diabetic NOD Mice
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+ T
cells.
CD28 costimulation sensitizes CD252 T cells to apoptosis
in mixed cultures
Measurements of Treg cell apoptosis in CD3-activated mixed
cultures are limited by CD25 expression in naı ¨ve/effector CD4
+ T
cells as a feature of activation. Evaluation of mixed cultures reveals
conversion to express CD25 of 85% of the CD4
+CD25
2 T cells
(Figure 5A), making the contribution naturally occurring CD25
+
(7.661.3%) and FoxP3
+ cells (10.963%) relatively insignificant.
Assuming a negligible contribution of Treg to the fraction of CD3-
activated CD4
+ T cells, the responsive cells display superior
survival in mixed cultures (p,0.001 vs isolated cells, Figure 5B).
Decreased fractional apoptosis is partially attributed to fast cycling
of viable cells (Figure 5C), diluting the apoptotic subset.
Superposed CD28 costimulation results in remarkable high death
rates on unresponsive cells (Figure 5D), which is even more
pronounced in mixed cultures (p,0.001 vs isolated cells). Notably,
the proliferative responses to CD3/CD28 stimulation are largely
amplified in mixed cultures (p,0.005, Figure 5E), suggesting
synergism with other factors secreted by adjacent cells. Overall,
these data demonstrate that CD3 stimulation activates naı ¨ve/
effector CD25
2 T cells to proliferate at fast rates and display
activation markers. Expansion of viable cells is the likely reason for
decreased fractional apoptosis of cells responsive to stimulation.
Independently, CD28 costimulation sensitizes both unresponsive
and responsive subsets to apoptosis, though the latter is hindered
by a 4-fold increase in cycling rates.
Discussion
Measurements performed in isolated cell subsets are easy,
precise and allow significant manipulation of multiple experimen-
tal variables. Here we provide evidence that assessment of
spontaneous apoptosis is dominated by isolation procedures and
culture conditions. The first significant observation is wide
variability in cell viability in fresh lymphocyte samples, which
question whether such measurements can be used to assess
differential apoptosis in vivo under various physiological and
pathological conditions. Successful harvesting of cells from new
onset diabetic mice with less than 1% dead cells, predominant
staining with death probes and low specific staining of apoptosis
imply that few apoptotic cells are found in lymphoid organs in situ.
Although T cells are submitted to negative regulation both in the
thymus and the periphery, dead cells are short lived in vivo due to
efficient clearance mechanisms [41–44]. Our current observations
argue that the differences in fresh samples might originate from
differential susceptibilities to death under various pathological
conditions, which are accentuated by the isolation procedure.
Although susceptibility to apoptosis is a feature of cells isolated
from wild type and NOD mice, measurements of apoptosis have
been used to suggest that increased apoptosis of CD4
+CD25
high T
cells, obtained either by immunomagnetic isolation or FACS
sorting, is a mechanism involved in the pathogenesis of
autoimmune diabetes [18–21]. These data have to be carefully
evaluated when used to monitor disease evolution [45], as
penetration of death probes might be a primary consequence of
membrane permeabilization during isolation rather than a
physiological feature of the disease [46]. Likewise, it remains to
be determined what is the impact of isolation on the suppressive
function of apoptosis-sensitive, non-proliferating Treg on effector
cells in diabetic patients [47] and NOD mice [34].
Our data confirm the higher sensitivity of isolated CD25
+ Tc e l l s
to apoptosis [18–21], and reciprocal modulation of this sensitivity
between naı ¨ve/effector and suppressor T cells [33,34]. However, all
parameters measured in isolated subsets differed from mixed
splenocyte cultures, including proliferation rates, apoptotic death,
responses to cytokines, TCR-associated stimulation and costimula-
tion. These functions reflect primarily transition to controlled yet
arbitrary culture conditions that differ substantially from the
physiological environment of these cells. Treg operate within the
infiltrates at the site of inflammation [48,49], under continuously
changing cytokine and cellular environments and antigenic stimuli
[12,50]. We have previously postulated that transition to arbitrary in
vitro culture conditions causes proliferative anergy [37], whereas
Treg cycle at faster rates than naı ¨ve/effector T cells in vivo
[28,31,46]. CD25
2 naı ¨ve/effector cells display a relatively auton-
omous behavior in respect to the culture conditions [34], however
elimination of T cells and other cell subsets increases the
susceptibility of isolated Treg to apoptosis, by removing both soluble
factors and signals mediated by cell-to-cell interactions. We
attempted to reduce differences originating from the isolation
procedure per se by exposure of the mixed cultures to the same
processing technique without performing the separation. Therefore,
starting from fresh samples with similar contents of dead cells, the
variations in cell behavior originate primarily from extrinsic factors
under our culture conditions. Comparative analysis showed that
bothpro-andanti-apoptoticfactorssecretedbyothercellswithinthe
culture affect the viability of CD25
+ and CD25
highFoxP3
+ Tc e l l s .
Exogenous IL-2 supplementation reversed the excessive death
of isolated CD25
+ T cells and restored their proliferative activity,
identifying this cytokine as an anti-apoptotic factor secreted by
other cell types. IL-2 is produced only by effector and some
adaptive Treg, but not by naturally occurring Treg cells [51,52],
and inhibition of its secretion from naı ¨ve/cytotoxic T cells is a
major mechanism of suppression [29,38,39]. The ensuing state of
cytokine deprivation induces apoptosis in effector cells [53], and
also serves as a regulatory feedback mechanism that downsizes
Treg function [37] towards termination of the inflammatory
reaction [17]. In addition to an essential role of this cytokine in
Treg development and peripheral function [54,55], the require-
ment for its exogenous supplementation has been documented in
numerous prior in vitro studies of isolated CD25
+ T cells [38–40]
and in vivo [56]. Furthermore, exogenous IL-2 supplementation
improves Treg viability in mixed cultures, associating expression
of the high affinity IL-2 receptor with responsiveness to the
cognate ligand. These data also indicate that baseline IL-2
production in mixed cultures is insufficient to exert maximal
protection of Treg from apoptosis. Although the isolation
procedure also eliminates other cytokines released by adjacent
cells that simulate the activity of IL-2 through activation of other
Figure 4. Sensitivity to apoptosis of isolated CD4
+ T cells under CD3 and CD28 stimulation. CD25
2 and CD25
+ T cells isolated from new
onset diabetic NOD mice were stimulated with beads conjugated to anti-CD3 and anti-CD28. A. Apoptosis during 48 hours of incubation under CD3
(n=4) and CD3/CD28 stimulation (n=4). B. Proliferation rates determined from CFSE dilution. C. Isolated CD25
2 T cells convert to express CD25
without FoxP3 priming during 48 hours of CD3/CD28 stimulation. Isolated CD25+ T cells sustain Cd25 and FoxP3 expression during Cd3/Cd28
stimulation. D. Proliferation rates of cells unresponsive to stimulation (CD25
2) and the subset that upregulates CD25 expression (CD25
2RCD25
+)
and representative plots of CFSE dilution. E. Fractional apoptosis of responsive and unresponsive CD25
2 T cells under CD3/CD28 stimulation (n=4)
and representative plots of apoptosis.
doi:10.1371/journal.pone.0015684.g004
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might contribute to dominant diabetogenic cell activity in NOD
mice [56,57].
Partial reversal of Treg hypersensitivity to apoptosis by soluble
factors in conditioned medium indicates that cellular interactions
affect viability. Similar to the requirement for cell-to-cell
Figure 5. Apoptosis under CD3/CD28 stimulation. A. Representative plots demonstrating upregulation of CD25 in response to CD3/CD28
stimulation in mixed splenocyte cultures. B. Spontaneous apoptosis in isolated (n=4) and gated cells (n=5) in reference to responsiveness (CD25
expression) to CD3-activation, assuming negligible contribution of naturally occurring CD25
+ T cells in mixed cultures. C. Proliferation rates under
CD3-activation of responsive (CD25
2RCD25
+) and non-responsive (CD25
2) subsets in isolated CD25
2 T cells (n=4) and in mixed cultures (gated,
n=5). D. Fractional apoptosis of responsive and non-responsive cells to CD3/CD28 stimulation in mixed cultures (n=5). E. Proliferation rates under
CD3/CD28 stimulation.
doi:10.1371/journal.pone.0015684.g005
T Cell Apoptosis in Diabetic NOD Mice
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[39,40], reciprocal signals modulate the sensitivity to apoptosis.
Both CD3 stimulation and CD28 costimulation converge to
impose additive effects on the viability of isolated Treg, which
serve as survival factors independent of IL-2 [33,34,40]. Antigenic
stimulation is generally necessary to initiate Treg proliferation
[58], but TCR engagement is not required for functional
activation [59,60]. This dissociation between Treg function and
proliferation might be responsible for the relative resistance to
apoptosis [29,30]. At the same time, CD3/CD28 stimulation
sensitizes isolated naı ¨ve/effector cells to spontaneous death in
culture. Robust proliferation induced by CD3/CD28 stimulation
hinders the real sensitivities to apoptosis, as dead cells are diluted
within fast-expanding viable cells. Therefore, measurements of cell
death should include proliferation rates to determine the true
meaning of fractional apoptosis determined under various
stimulatory conditions. The evident sensitization to apoptosis of
isolated CD25
2 naı ¨ve/effector T cells by CD3 ligation was less
pronounced in mixed cultures, in particular the responsive subset.
In variance, CD28 appears to increase the susceptibility to
spontaneous apoptosis despite fast cycling of the stimulated cells,
likely through indirect mechanisms that might involve stimulation
of cytokine secretion. Nevertheless, these data demonstrate
significant variations in susceptibility to apoptosis induced by cell
isolation, which attenuates the differential responses to TCR-
associated stimulation and costimulation. The presence of adjacent
cells involves both pro- and anti-apoptotic signals even under
conditions that mediate hyperstimulation of effector cells.
Data presented here emphasize that measurements apoptosis in
isolated cell subsets deviate significantly from their behavior in
mixed cultures, a feature that reflects a limited capacity of such
assays to generate insights into physiological and pathological
conditions. Reciprocal influences between effector and regulatory
cells are also influenced by other cell types and involve both
soluble factors and cell-to-cell interactions. In addition to IL-2 as a
dominant cytokine in function of Treg, TCR-associated stimula-
tion and co-stimulation have the capacity to modulate the
sensitivity of T cells to apoptosis. Variations in cell death affect
the Teff:Treg ratios and consequently impact the severity of
inflammatory insulitis in the murine model of type 1 diabetes.
Importantly, the data presented here question the validity of the
contention that polarized sensitivity to apoptosis measured in
isolated subsets underlie the dominance of diabetogenic clones in
NOD mice and human diabetics.
Materials and Methods
Mice
Mice used in this study were C57BL/6 and non obese diabetic
(NOD) purchased from Jackson Laboratories (Bar Harbor, ME).
The inbred colonies were housed in a barrier facility. The
Institutional Animal Care Committee of the Schneider Medical
Center has approved all procedures #022B6229 dated 4.1.2009.
Blood glucose was monitored between 9–11 AM in tail blood
samples at weekly intervals using a glucometer (Accu-Chek Sensor,
Roche Diagnostics, USA). Diabetes was defined as two consecutive
blood glucose measurements above 200 mg/dl.
Cell preparation
Spleens and lymph nodes were harvested and gently minced on
a4 0mM nylon mesh in HBSS (Kibbutz Beit Haemek, Israel) to
prepare single cell suspensions. Lymphocytes were enriched by
centrifugation over 1.5 ml Lympholyte-M (Cedarlane, Ontario,
Canada) and T cells were collected after immunomagnetic
depletion using antibodies against MAC-1, GR-1. NK1.1 and
B220 [61]. All antibodies were obtained from hybridoma cell
cultures (ATCC). Antibody-coated cells were washed twice with
PBS containing 2% FCS and were incubated with sheep-anti-rat
IgG conjugated to M-450 magnetic beads at a ratio of 4–5 beads
per cell (Dynal Inc.). Conjugated cells were precipitated by
exposure to a magnetic field. The purity of T cell elution was
reassessed by flow cytometry using primary labeled monoclonal
antibodies against CD4 and CD8. For flow cytometry the red cells
were removed by ammonium chloride lysis for 4 minutes at room
temperature. The reaction was arrested with excess ice-cold
solution and cells were washed.
Isolation of cells according to CD25 expression
CD25
2 and CD25
+ subsets of CD4
+ T cells are isolated from
the spleens and mesenteric lymph nodes using the CD4
+CD25
+
Regulatory T cell isolation kit (Miltenyi Biotec, Bergisch-
Gladbach, Germany) [62]. In first stage lymphocytes were mixed
with a cocktail of biotinylated antibodies against CD8, CD11b,
CD45R, CD49b and Ter-119 and incubated with magnetic beads
conjugated to anti-biotin antibody. Elution through a column
under a magnetic field enriched the unlabeled CD4
+ T cells. In
second stage CD25
+ was stained with PE-labeled monoclonal
antibodies, mixed with anti-PE magnetic microbeads and
positively selected by passage through a second column under a
magnetic field. Purity was evaluated using FITC-labeled mono-
clonal antibodies. Immunomagnetic isolation of cells from NOD
females yields a CD4
+CD25
2 subset contaminated with
0.760.4% and 3.661.3% CD25
+ and FoxP3
+ cells respectively,
and a CD4
+CD25
+ subset of which 7564% expressed FoxP3, and
are contaminated with 1768% CD25
2/low cells.
Flow cytometry
Cells were labeled by incubation for 45 minutes at 4uC with the
appropriate antibodies conjugated to fluorescein isothyocyanate
(FITC), phycoerythrin (PE), allophycocyanin (APC) and peridinin
chlorophyll a-protein (PerCP, BD Pharmingen, San Diego, CA):
CD4 (clone RM 4–5), CD8 (clone 53-6.7), CD25 (clone PC61.5)
[61,62]. Cells were washed in PBS, incubated for 45 min at 4uC
with labeled primary mAb or counterstained with a fluorochrome-
labeled secondary mAb. FoxP3 was determined following
permeabilization and intracellular staining with a PE-labeled
antibody (Foxp3 staining buffer set NRRF-30, eBioscience, San
Diego, CA). Antibodies were purchased from BD Pharmingen and
eBioscience. Cell death and apoptosis were determined in cells
incubated with 5 mg/ml 7-aminoactinomycin-D (7-AAD, Sigma,
St. Lois, MO) and Annexin-V (IQ products, Groningen, The
Netherlands). Measurements were performed with a Vantage SE
flow cytometer (Becton Dickinson, Franklin Lakes, NJ). Positive
staining was determined on a log scale, normalized with control
cells stained with isotype control antibodies.
In vitro apoptosis
A concentration of 2610
6 cells/ml was prepared in DMEM
supplemented with 2 mM L-glutamine, 1 mM sodium pyruvate,
13.6 mM folic acid, 270 mM L-asparagine, 548 mM L-arginine
HCL, 10 mM HEPES, 50 mM2 b-Mercaptoethanol, 100 mg/ml
streptomycin, 100 U/ml penicillin and 5% heat-inactivated fetal
bovine serum (FBS) (MLR medium) [61–63]. All ingredients were
purchased from Beit Haemek and Sigma (St. Lois, MO). Cells
were stimulated by exogenous supplementation of 2000 U/ml IL-
2 (Peprotech, London, UK), and beads conjugated to anti-CD3
and anti-CD28 (Invitrogen, Oslo, Norway) at a bead:cell ratio of
1:1. For determination of apoptosis in reference to FoxP3
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were stained for FoxP3 expression.
Proliferation assay
Splenocytes and lymphocytes were incubated at room temper-
ature for 7 minutes with 10 mM 5-(and 6-)-carboxyfluorescein
diacetate succinimidyl ester (CFSE, Molecular Probes, Carlsbad,
CA), and uptake was arrested by addition of 50% FCS. Stained
cells were washed with PBS and cultured at 37uC in a humidified
5% CO2 atmosphere for 3 days in MLR medium containing 1%
heat-inactivated mouse serum [63]. Cells were stimulated with
5 mM concanavalin A (ConA, Sigma) and isolated CD25
+ T cells
were incubated with 20 U/ml IL-2. All proliferation assays were
performed in triplicates. Suppression of T cell proliferation was
performed in stimulated mixed cultures. Isolated target
CD4
+CD25
2 T cells were labeled with CFSE and stimulated
with an equal number of CD3/CD28 beads. Proliferation was
assessed after 48 hours with and without the addition of
CD4
+CD25
+ T cells at various ratios. CFSE dilution was analyzed
in flow cytometry by gating on the live lymphocytes and
proliferation was quantified the ModFit software (Verity Software
House, Topsham, ME).
Statistical analysis
Data are presented as means 6 standard deviations for each
experimental protocol. Results in each experimental group were
evaluated for reproducibility by linear regression of duplicate
measurements. Differences between the experimental protocols
were estimated with a post hoc Scheffe t-test and significance was
considered at p,0.05.
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